HHealth Read More Combined CDK4/6 and EGFR inhibition improves pancreatic cancer therapyMarch 13, 2026 Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS…